Pharmaceutical Products and Raw Materials Trading from Dubai to Asia

Active Pharmaceutical Ingredients (APIs)

Active pharmaceutical ingredients are the core of what Equihealth does. APIs are the biologically active compounds in a finished drug product — the component that produces the therapeutic effect. Sourcing them reliably, from manufacturers with the correct quality documentation, is one of the most operationally demanding parts of the pharmaceutical supply chain.
Equihealth sources bulk APIs from manufacturers in India, China, and the European Union. Our target buyers are pharmaceutical formulation manufacturers in Bangladesh, Pakistan, Singapore, Indonesia, Vietnam, Malaysia, Thailand, Hong Kong, and other markets across Asia.
API Trading and Distribution

Pharmaceutical Raw Materials

Pharmaceutical manufacturing requires a range of non-active raw materials: excipients, binders, fillers, coating agents, solvents, and processing intermediates. Equihealth sources pharmaceutical-grade raw materials from qualified manufacturers across India, China, and Europe. Quality documentation is managed from point of origin through to the end buyer.

Finished Pharmaceutical Goods

Equihealth trades completed dosage forms — tablets, capsules, liquids, topical preparations, and other finished forms — sourced from pharmaceutical manufacturers and supplied to distributors, importers, and commercial buyers across our target markets. Finished goods trading involves careful attention to destination-market registration requirements, managed through our Bill-to Ship-to structure.

Para-Pharmaceutical Products

Para-pharmaceutical products span over-the-counter health products, nutritional supplements, medicated skincare, vitamins, minerals, and health-adjacent consumer items sold through pharmacy and healthcare retail channels. This is a growing category across Southeast Asia, where consumer health spending is rising alongside increasing urbanisation.

Beauty and Personal Care

Equihealth trades cosmetic raw materials and finished personal care products as part of its broader healthcare portfolio. This includes active cosmetic ingredients, formulation bases, and finished skincare, haircare, and hygiene products. Our sourcing network in Europe, India, and China covers both raw material and finished product ends of this category.

Surgical and Medical Diagnostic Equipment

Equihealth sources and trades surgical instruments, medical devices, and diagnostic equipment through its international trading structure. This category serves hospitals, clinics, diagnostic laboratories, and medical procurement bodies in our target markets. We work with suppliers whose products carry the documentation appropriate to the destination market.

Industrial Chemicals

Equihealth trades industrial-grade chemicals for use in regulated manufacturing processes — intermediates, solvents, and processing agents used in pharmaceutical manufacturing and allied industrial sectors. All industrial chemical transactions are conducted in compliance with applicable export control, hazardous goods, and trade compliance regulations.

How We Source and Supply

Every product category Equihealth trades follows the same commercial structure. We identify qualified suppliers in our sourcing markets, establish commercial terms, and manage each transaction through our Bill-to Ship-to model. The supplier delivers directly to the end buyer. Equihealth issues the commercial invoice, manages the documentation, and takes responsibility for the full commercial relationship.
How the Bill-to Ship-to Model Works

Who We Supply

Our buyers are primarily pharmaceutical formulation manufacturers and producers of healthcare and allied goods operating in South Asia and Southeast Asia. These companies need consistent access to quality-assured raw materials and finished goods from established international manufacturers. Equihealth provides that access through a structured commercial relationship backed by supply chain partnerships across three continents.
For Manufacturers
Contact Equihealth

Frequently Asked Questions

Equihealth trades active pharmaceutical ingredients, pharmaceutical raw materials, finished pharmaceutical goods, para-pharmaceutical products, beauty and personal care items, surgical and medical diagnostic equipment, and industrial chemicals. All categories are traded through our Bill-to Ship-to model from Dubai Commercity, UAE.

No. Equihealth is a trading company. We source from qualified manufacturers in India, China, and Europe and supply to buyers and manufacturers across Asia and other target markets.

APIs are the biologically active compounds that produce the therapeutic effect in a finished drug. Pharmaceutical raw materials are the non-active components — excipients, binders, solvents — used in formulation. Both are necessary for producing finished pharmaceutical goods, and Equihealth trades both categories.

Our primary sourcing markets are India, China, and the European Union — specifically Italy and France for EU-origin materials. These three regions account for the majority of global API and pharmaceutical raw material production.

Yes. Many of our target buyers are pharmaceutical manufacturers who need both APIs and raw materials for their production process. Equihealth can manage multiple product categories within a single trading relationship.